P/B
0,8
Genenta Science
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
$20.2M
Market Cap • 9/11/2026
2014
(12 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
Italy
Country
Valuation
P/S
—
P/EBITDA
614
P/OCF
—
P/FCF
—
P/E
—
BVPS
1,3
EPS
—
Market Cap
Market Cap
20,2M
EV
-3,9M
EV/Revenue
0
EV/EBITDA
-117,7
EV/EBIT
0
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-85,8%
Total Yield
-85,8%
Payout
0%
Retained Earnings
-73,4M
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
27,2%
Capex/OCF
-0,1%
SBC/OCF
—
% PPE
0,1%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Op. Income 5Y
-100%
CAGR Net Income 5Y
-60,5%
CAGR OCF 5Y
1,8%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
14,2
Quick Ratio
13,3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!